Optain Health Closes $26 Million Series A to Bring Oculomics to Primary Care and Beyond

Optain Health, a healthcare technology company specializing in AI-driven robotic retinal imaging and teleophthalmology, has closed an oversubscribed $26 million Series A funding round led by Insight Partners. The funding will accelerate the global rollout of Optain's platform, which enables non-invasive retinal screening for eye and systemic diseases. The round includes participation from seven major U.S. health systems and other investors, supporting deployments across healthcare networks and international expansion.